相关实验视频
Updated: Jun 14, 2025

03:36
Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
391
上调的DSG2促进瘤生长,并减少宫癌的免疫透
Gong Zhang1, Zhimin Chen2, Yuanpei Wang2
1Department of Hepatobiliary and Pancreatic Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
Pathology, research and practice
|September 3, 2024
概括
升高的德斯莫格林-2 (DSG2) 水平与宫癌 (CC) 预后不佳和免疫细胞透率降低相关. DSG2可能是用于CC诊断和治疗的有价值的生物标志物.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 德斯莫格林-2 (DSG2) 涉及各种疾病,但其在宫癌 (CC) 中的作用尚不清楚.
- 需要对DSG2在CC中的功能进行全面调查.
研究的目的:
- 用生物信息学和实验方法探索DSG2在宫癌 (CC) 的功能机制.
- 确定CC中DSG2的预后和诊断潜力.
主要方法:
- 使用生物信息学数据库 (GEPIA,ONCOMINE,LinkedOmics,MetaScape,HPA,OMICS,scRNA-seq) 来分析CC中的DSG2表达,预后,突变和途径.
- 在CC样本中使用qRT-PCR和西部涂抹量化DSG2表达.
- 进行了体外实验,以评估DSG2失调对宫细胞系的影响.
主要成果:
- 与正常组织相比,CC组织中的DSG2mRNA和蛋白质水平显著上调.
- 更高的DSG2表达与更差的预后,晚期癌症,更高的瘤等级和结节转移相关.
- DSG2上调降低了免疫细胞的透,提高了瘤的纯度.
- DSG2 敲除抑制了CC细胞系的扩散和入侵.
结论:
- 升高的DSG2与宫癌的预后不佳和免疫透率降低有关.
- DSG2显示出作为CC的治疗和诊断生物标志物的潜力.
相关概念视频
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K

